Neurodawn Pharmaceutical Co., Ltd.

This completed Phase 1 trial in 24 healthy adults checked whether an experimental injection called Y-3 changes how the body handles three common drugs: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants took these drugs alone and …

This early-stage study tested a single dose of the experimental drug Y-3 in 20 healthy adults to see if it is safe and how the body processes it. Participants received either 40 mg, 60 mg, or a placebo. The study is complete and focused on gathering basic safety and drug-level in…